An association between increased Src expression/activity and thyroid tumour aggressiveness is well-established, with Src inhibition reducing thyroid cancer cell proliferation and invasiveness in vitro and tumour growth and metastasis in vivo (39, 40, 41, 42, 43, 44). The gene discussed is SRC; the disease is thyroid gland carcinoma.